• Explore /
  • Poster
  • / Genomic landscape of acquired resistance to targeted therapies in patients with solid tumors: A study from the National Center for Precision Medicine (PRISM).

Genomic landscape of acquired resistance to targeted therapies in patients with solid tumors: A study from the National Center for Precision Medicine (PRISM).

Abstract Poster

Authors

null

Arnaud Bayle

Gustave Roussy Cancer Center, Villejuif, France

Arnaud Bayle , Laila Belcaid , Sophie Cousin , Lola-Jade Palmieri , Mariella Spalato , Mihaela Aldea , Damien Vasseur , Melissa Alame , Isabelle Soubeyran , Claudio Nicotra , Maud Ngocamus , Santiago Ponce , Yohann Loriot , Benjamin Besse , Ludovic Lacroix , Etienne Rouleau , Geoffrey R. Oxnard , Fabrice Barlesi , Fabrice Andre , Antoine Italiano

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Circulating Biomarkers

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3016)

DOI

10.1200/JCO.2022.40.16_suppl.3016

Abstract #

3016

Poster Bd #

8

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

ctDNA detection in patients with brain metastases arising from solid tumors.

ctDNA detection in patients with brain metastases arising from solid tumors.

First Author: Laura Alder

First Author: Laura Mezquita

First Author: Wei Wu

First Author: Pradeep Poonnen